Gentian Diagnostics
GENT
Oslo Børs
Medical Equipment & Services
Health Care
Less than 1K followers
Gentian Diagnostics is a medical diagnostics company that develops and manufactures in vitro diagnostic reagents for high-throughput analysers. Gentian’s expertise and focus lies within homogenous immunoassays, specifically infections, inflammations, kidney failures and congestive heart failures. The company headquarters and production facilities are located in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in key countries.
Read moreMarket cap
-
Turnover
-
Revenue
152.07M
EBIT %
10.34 %
P/E
-
Dividend yield-%
-
Financial calendar
6.5
2025
General meeting '25
7.5
2025
Interim report Q1'25
7.5
2025
Annual dividend
ShowingAll content types
Gentian Diagnostics: Invitation to presentation of fourth quarter results
GENT: Mandatory notification of trade
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools